NervGen Pharma Corp. (NGEN)

NervGen Pharma Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	86.79	22.07	17.27	11.66	22.45	16.93
Cash & Short-Term Investments	86.79	22.07	17.27	11.66	22.45	16.93
Cash Growth	453.70%	27.81%	48.10%	-48.07%	32.62%	202.38%
Accounts Receivable	-	0.01	0.1	-	-	-
Other Receivables	0.2	0.08	0.42	0.25	0.03	0.06
Receivables	0.2	0.09	0.51	0.25	0.03	0.06
Prepaid Expenses	2.59	0.39	0.29	0.11	0.08	0.07
Other Current Assets	0.23	0.25	0.94	0.5	0.59	0.36
Total Current Assets	89.81	22.8	19.01	12.52	23.15	17.42
Property, Plant & Equipment	-	-	-	0.2	0.3	0
Other Intangible Assets	0.38	0.41	0.46	0.52	0.43	0.47
Long-Term Accounts Receivable	-	-	0.01	-	-	-
Total Assets	90.19	23.21	19.49	13.24	23.88	17.9

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.03	0.03	0.03	3.32	2	0.35
Accrued Expenses	4.26	4.63	4.91	-	1.4	0.73
Current Portion of Leases	-	0.01	0.1	0.09	0.09	-
Other Current Liabilities	39.06	15.07	11.86	11.73	6.73	-
Total Current Liabilities	43.35	19.73	16.9	15.14	10.22	1.08
Long-Term Leases	-	-	0.01	0.11	0.2	-
Total Liabilities	43.35	19.73	16.91	15.25	10.41	1.08

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	140.55	103	81.19	58.93	57.41	42.4
Retained Earnings	-133.29	-146.76	-102.65	-78.15	-55.77	-35.05
Comprehensive Income & Other	39.58	47.24	24.03	17.21	11.82	9.46
Shareholders' Equity	46.84	3.48	2.58	-2.01	13.46	16.82
Total Liabilities & Equity	90.19	23.21	19.49	13.24	23.88	17.9

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	-	0.01	0.11	0.2	0.28	-
Net Cash (Debt)	86.79	22.06	17.16	11.46	22.17	16.93
Net Cash Growth	455.74%	28.55%	49.72%	-48.29%	30.95%	202.38%
Net Cash Per Share	1.09	0.30	0.25	0.19	0.42	0.43
Filing Date Shares Outstanding	107.52	80.93	70.99	69.93	59.13	46.23
Total Common Shares Outstanding	106.41	79.65	70.33	59.61	58.78	46.19
Working Capital	46.46	3.07	2.11	-2.62	12.93	16.34
Book Value Per Share	0.44	0.04	0.04	-0.03	0.23	0.36
Tangible Book Value	46.46	3.07	2.11	-2.53	13.03	16.35
Tangible Book Value Per Share	0.44	0.04	0.03	-0.04	0.22	0.35

Data Source: S&P Global Market Intelligence Last updated: Oct 16, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 19, 2026

Data Sources Report a data error